Ascendis Pharma Stock (NASDAQ:ASND), Quotes and News Summary

Q: What sector and industry does Ascendis Pharma (ASND) operate in?

Ascendis Pharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Ascendis Pharma Stock (NASDAQ: ASND) stock price, news, charts, stock research, profile.

Open	$125.270
Close	$122.800
Volume / Avg.	503.754K / 345.951K
Day Range	122.450 - 126.000
52 Wk Range	83.750 - 161.000
Market Cap	$6.952B
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	27
Short Interest	9.41%
Days to Cover	13.72

Recent News

FDA Pushes Review Date For Ascendis Pharma's Hormone Disorder Candidate By Three Months

Ascendis Pharma announces FDA's extension of the review date for TransCon PTH for adults with hypoparathyroidism to August 14, 2024. TransCon PTH aims to address low calcium levels due to hypoparathyroidism.

Vandana Singh

These Five Small-Cap Stocks Under The Radar Are Expected To Surge, Says Stock Researcher

Ethan Meyers, the research director at Westfield Capital Management, has a knack for identifying promising investments that have proven fruitful, especially for the Harbor Small Cap Growth Fund, where Westfield is a subadviser.

Bibhu Pattnaik

Ascendis Pharma's Growth Hormone Deficiency Candidate Outperforms in Phase 3 Trial

Ascendis Pharma A/S (NASDAQ: ASND) released topline results from Phase 3 foresiGHt trial to compare the efficacy and safety of TransCon hGH (lonapegsomatropin) with placebo and daily hGH (human growth hormone, somatropin) in adults with growth

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trend

Dec 23

Feb

Mar

Apr

May

Buy

Hold

Sell

Strong Sell

Analyst Rating

3.5

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Ascendis Pharma (ASND) stock?

You can purchase shares of Ascendis Pharma (NASDAQ: ASND) through any online brokerage.

View our list of the best stock brokerages.

Who are Ascendis Pharma's (ASND) competitors?

Other companies in Ascendis Pharma’s space includes: Legend Biotech (NASDAQ:LEGN), Sarepta Therapeutics (NASDAQ:SRPT), Exact Sciences (NASDAQ:EXAS), Neurocrine Biosciences (NASDAQ:NBIX) and Cerevel Therapeutics Hldg (NASDAQ:CERE).

What is the target price for Ascendis Pharma (ASND) stock?

The latest price target for Ascendis Pharma (NASDAQ: ASND) was reported by Morgan Stanley on Thursday, May 16, 2024. The analyst firm set a price target for 140.00 expecting ASND to rise to within 12 months (a possible 14.01% upside). 36 analyst firms have reported ratings in the last year.

Current Stock Price for Ascendis Pharma (ASND)?

The stock price for Ascendis Pharma (NASDAQ: ASND) is $122.8 last updated May 16, 2024 at 4:00 PM EDT.

Does Ascendis Pharma (ASND) pay a dividend?

There are no upcoming dividends for Ascendis Pharma.

When is Ascendis Pharma (NASDAQ:ASND) reporting earnings?

Ascendis Pharma’s Q1 earnings are confirmed for Thursday, May 2, 2024.

Is Ascendis Pharma (ASND) going to split?

There is no upcoming split for Ascendis Pharma.

What sector and industry does Ascendis Pharma (ASND) operate in?

Ascendis Pharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

-

-

-

-

-

-

-

-

-

-

-

-

-

-